David A A Baranger1, Catherine H Demers2, Nourhan M Elsayed3, Annchen R Knodt4, Spenser R Radtke4, Aline Desmarais2, Lauren R Few5, Arpana Agrawal5, Andrew C Heath5, Deanna M Barch6, Lindsay M Squeglia7, Douglas E Williamson8, Ahmad R Hariri4, Ryan Bogdan9. 1. Department of Psychological and Brain Sciences, Washington University, St. Louis, Missouri. Electronic address: dbaranger@gmail.com. 2. Department of Psychological and Brain Sciences, Washington University, St. Louis, Missouri. 3. Department of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina. 4. Department of Psychology and Neuroscience, Duke University, Durham, North Carolina. 5. Department of Psychiatry, Washington University, St. Louis, Missouri. 6. Department of Psychological and Brain Sciences, Washington University, St. Louis, Missouri; Department of Psychiatry, Washington University, St. Louis, Missouri. 7. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina. 8. Department of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina; Durham VA Medical Center, Durham, North Carolina. 9. Department of Psychological and Brain Sciences, Washington University, St. Louis, Missouri. Electronic address: rbogdan@wustl.edu.
Abstract
BACKGROUND: Alcohol use has been reliably associated with smaller subcortical and cortical regional gray matter volumes (GMVs). Whether these associations reflect shared predisposing risk factors or causal consequences of alcohol use remains poorly understood. METHODS: Data came from 3 neuroimaging samples (N = 2423), spanning childhood or adolescence to middle age, with prospective or family-based data. First, we identified replicable GMV correlates of alcohol use. Next, we used family-based and longitudinal data to test whether these associations may plausibly reflect a predispositional liability for alcohol use or a causal consequence of alcohol use. Finally, we used heritability, gene-set enrichment, and transcriptome-wide association study approaches to evaluate whether genome-wide association study-defined genomic risk for alcohol consumption is enriched for genes that are preferentially expressed in regions that were identified in our neuroimaging analyses. RESULTS: Smaller right dorsolateral prefrontal cortex (DLPFC) (i.e., middle and superior frontal gyri) and insula GMVs were associated with increased alcohol use across samples. Family-based and prospective longitudinal data suggest that these associations are genetically conferred and that DLPFC GMV prospectively predicts future use and initiation. Genomic risk for alcohol use was enriched in gene sets that were preferentially expressed in the DLPFC and was associated with replicable differential gene expression in the DLPFC. CONCLUSIONS: These data suggest that smaller DLPFC and insula GMV plausibly represent genetically conferred predispositional risk factors for, as opposed to consequences of, alcohol use. DLPFC and insula GMV represent promising biomarkers for alcohol-consumption liability and related psychiatric and behavioral phenotypes.
BACKGROUND:Alcohol use has been reliably associated with smaller subcortical and cortical regional gray matter volumes (GMVs). Whether these associations reflect shared predisposing risk factors or causal consequences of alcohol use remains poorly understood. METHODS: Data came from 3 neuroimaging samples (N = 2423), spanning childhood or adolescence to middle age, with prospective or family-based data. First, we identified replicable GMV correlates of alcohol use. Next, we used family-based and longitudinal data to test whether these associations may plausibly reflect a predispositional liability for alcohol use or a causal consequence of alcohol use. Finally, we used heritability, gene-set enrichment, and transcriptome-wide association study approaches to evaluate whether genome-wide association study-defined genomic risk for alcohol consumption is enriched for genes that are preferentially expressed in regions that were identified in our neuroimaging analyses. RESULTS: Smaller right dorsolateral prefrontal cortex (DLPFC) (i.e., middle and superior frontal gyri) and insula GMVs were associated with increased alcohol use across samples. Family-based and prospective longitudinal data suggest that these associations are genetically conferred and that DLPFC GMV prospectively predicts future use and initiation. Genomic risk for alcohol use was enriched in gene sets that were preferentially expressed in the DLPFC and was associated with replicable differential gene expression in the DLPFC. CONCLUSIONS: These data suggest that smaller DLPFC and insula GMV plausibly represent genetically conferred predispositional risk factors for, as opposed to consequences of, alcohol use. DLPFC and insula GMV represent promising biomarkers for alcohol-consumption liability and related psychiatric and behavioral phenotypes.
Authors: Bridget F Grant; Risë B Goldstein; Tulshi D Saha; S Patricia Chou; Jeesun Jung; Haitao Zhang; Roger P Pickering; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin Journal: JAMA Psychiatry Date: 2015-08 Impact factor: 21.596
Authors: Lindsay M Squeglia; Susan F Tapert; Edith V Sullivan; Joanna Jacobus; M J Meloy; Torsten Rohlfing; Adolf Pfefferbaum Journal: Am J Psychiatry Date: 2015-05-18 Impact factor: 18.112
Authors: Katie A McLaughlin; Jennifer Greif Green; Michael J Gruber; Nancy A Sampson; Alan M Zaslavsky; Ronald C Kessler Journal: Arch Gen Psychiatry Date: 2010-02
Authors: Michael Windle; Joshua C Gray; Karlo Mankit Lei; Allen W Barton; Gene Brody; Steven R H Beach; Adrianna Galván; James MacKillop; Uraina S Clark; Lawrence H Sweet Journal: Drug Alcohol Depend Date: 2018-03-14 Impact factor: 4.492
Authors: Peter Kochunov; Neda Jahanshad; Daniel Marcus; Anderson Winkler; Emma Sprooten; Thomas E Nichols; Susan N Wright; L Elliot Hong; Binish Patel; Timothy Behrens; Saad Jbabdi; Jesper Andersson; Christophe Lenglet; Essa Yacoub; Steen Moeller; Eddie Auerbach; Kamil Ugurbil; Stamatios N Sotiropoulos; Rachel M Brouwer; Bennett Landman; Hervé Lemaitre; Anouk den Braber; Marcel P Zwiers; Stuart Ritchie; Kimm van Hulzen; Laura Almasy; Joanne Curran; Greig I deZubicaray; Ravi Duggirala; Peter Fox; Nicholas G Martin; Katie L McMahon; Braxton Mitchell; Rene L Olvera; Charles Peterson; John Starr; Jessika Sussmann; Joanna Wardlaw; Margie Wright; Dorret I Boomsma; Rene Kahn; Eco J C de Geus; Douglas E Williamson; Ahmad Hariri; Dennis van 't Ent; Mark E Bastin; Andrew McIntosh; Ian J Deary; Hilleke E Hulshoff Pol; John Blangero; Paul M Thompson; David C Glahn; David C Van Essen Journal: Neuroimage Date: 2015-03-04 Impact factor: 6.556
Authors: Kenneth S Kendler; Charles O Gardner; Matt Hickman; Jon Heron; John Macleod; Glyn Lewis; Danielle M Dick Journal: J Stud Alcohol Drugs Date: 2014-07 Impact factor: 2.582
Authors: Hilary K Finucane; Brendan Bulik-Sullivan; Alexander Gusev; Gosia Trynka; Yakir Reshef; Po-Ru Loh; Verneri Anttila; Han Xu; Chongzhi Zang; Kyle Farh; Stephan Ripke; Felix R Day; Shaun Purcell; Eli Stahl; Sara Lindstrom; John R B Perry; Yukinori Okada; Soumya Raychaudhuri; Mark J Daly; Nick Patterson; Benjamin M Neale; Alkes L Price Journal: Nat Genet Date: 2015-09-28 Impact factor: 38.330
Authors: Jeremy Harper; Stephen M Malone; Sylia Wilson; Ruskin H Hunt; Kathleen M Thomas; William G Iacono Journal: Biol Psychiatry Date: 2021-01-20 Impact factor: 13.382
Authors: Briana Lees; Alexis M Garcia; Jennifer Debenham; Anna E Kirkland; Brittany E Bryant; Louise Mewton; Lindsay M Squeglia Journal: Neuropharmacology Date: 2021-02-16 Impact factor: 5.250
Authors: Paweł Wiśniewski; Pierre Maurage; Andrzej Jakubczyk; Elisa M Trucco; Hubert Suszek; Maciej Kopera Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2021-07-03 Impact factor: 5.067
Authors: Sarah E Paul; Alexander S Hatoum; Jeremy D Fine; Emma C Johnson; Isabella Hansen; Nicole R Karcher; Allison L Moreau; Erin Bondy; Yueyue Qu; Ebony B Carter; Cynthia E Rogers; Arpana Agrawal; Deanna M Barch; Ryan Bogdan Journal: JAMA Psychiatry Date: 2021-01-01 Impact factor: 25.911